In millions, except per share items | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 |
| 10-K | 10-Q | 10-Q | 10-Q | 10-K |
Revenues | | | | | |
Cost of Revenues | | | | | |
Gross Profit | | | | | |
Operating Expenses | | | | | |
Research and development | | | | | |
Sales and marketing | | | | | |
General and administrative | | | | | |
Acquisition related costs | | | | | |
Amortization of intangible assets | | | | | |
Impairment of Goodwill | | | | | |
Change in fair value of earnout payable | | | | | |
Total Operating Expenses | | | | | |
Loss from Operations | | | | | |
Other Income (Expense) | | | | | |
Interest income, net | | | | | |
Change in fair value of derivative liability | | | | | |
Other income (expense), net | | | | | |
Total Other Income (Expense) | | | | | |
Net Loss, before tax | | | | | |
Income tax benefit/(provision) | | | | | |
Net Loss | | | | | |
Unrealized foreign exchange gain/(loss) from cumulative translation adjustments | | | | | |
Comprehensive Loss | | | | | |
Basic weighted average shares outstanding | | | | | |
Diluted weighted average shares outstanding | | | | | |
Basic net loss per share | | | | | |
Diluted net loss per share | | | | | |